Eicosanoids, aspirin-intolerance and the upper airways - Current standards and recent improvements of the desensitization therapy

Journal of Physiology and Pharmacology

Volumn 57, Issue SUPPL. 12, 2006, Pages 5-13

  Pfaar, Oliver ^a,b   Klimek, L ^a  

^a Center for Rhinology and Allergology   (Germany)

^b Center for Rhinology and Allergology   (Germany)

Author keywords

Aspirin desensitization; Aspirin intolerance; Aspirin sensitive; Intravenous route; Nasal polyps; Samter triad

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CORTICOSTEROID; DICLOFENAC; DIFLUNISAL; ETODOLAC; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; ICOSANOID; INDOMETACIN; KETOPROFEN; KETOROLAC; LYSINE ACETYLSALICYLATE; MECLOFENAMIC ACID; MEFENAMIC ACID; MELOXICAM; NAPROXEN; NIMESULIDE; OXYPHENBUTAZONE; PARACETAMOL; PHENYLBUTAZONE; PIROXICAM; PLACEBO; ROFECOXIB; SALSALATE; SULINDAC; TOLMETIN; UNINDEXED DRUG;

ARACHIDONIC ACID METABOLISM; ASTHMA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DESENSITIZATION; DISEASE COURSE; DRUG DOSE ESCALATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG POTENTIATION; DRUG WITHDRAWAL; FATTY ACID SYNTHESIS; HUMAN; MODERATE PERSISTENT ASTHMA; NOSE POLYP; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RHINOSINUSITIS; SEVERE PERSISTENT ASTHMA; SINUSITIS; STOMACH DISEASE; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; ASPIRIN; ASTHMA; CLINICAL TRIALS AS TOPIC; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; EICOSANOIDS; HUMANS; NASAL POLYPS; RESPIRATORY SYSTEM;

EID: 34147188497     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Hirschberg VG. Anaphylactoid reaction to aspirin (1902) (classical article). Allergy Proc 1990; 11: 249-252.
2. Widal MF, Abrami P, Lenmoyez J. Anaphylaxie et idiosyncrasie. Presse Med 1922; 30: 189-192.
3. Samter M, Beers RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968; 68: 975-983.
4. Szczeklik A, Stevenson DD. Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003; 111: 913-921.
5. Babu KS, Salvi S. Aspirin and Asthma. Chest 2000; 118: 1470-1478.
6. Pfaar O, Klimek L. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements. Curr Opin Allerg Clin Immunol 2006; 6: 161-166.
7. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000; 16(3): 432-436.
8. Szczeklik A, Sanak M, Niz E, Kielbasa B. Aspirin intolerance and the cyclooxygenase.leukotriene pathways. Curr Opin Pulm Med 2004; 10: 51-56.
9. Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002; 89(5): 474-478.
10. Szczeklik A, Nizankowska E. Clinical features and diagnosis of aspirin induced asthma. Thorax 2000; 55 (Suppl 2): 42-44.
11. Bachert C, Watelet JB, Gevaert P, Van Cauwenberge P. Pharmacological management of nasal polyposis. Drugs 2005; 65(11): 1537-1552.
12. Picado C, Mullol J. The nose in aspirin-sensitive asthma. In Eicosanois, aspirin and asthma. A Szczeklik, RJ Gryglewski, J Vane (eds). New York, Marcel Dekker 1998 pp. 493-505.
13. Pawliczak R, Lewandowska-Polak A, Kowalski ML. Pathogenesis of nasal polyps: an update. Curr Allergy Asthma Rep 2005; (6): 463-471.
14. Min JW, Jang AS, Park SM, et al. Comparison of plasma eotaxin family level in aspirin-induced and aspirin-tolerant asthma patients. Chest 2005; 128(5): 3127-3132.
15. Molnar-Gabor E, Endreffy E, Rozsasi A: HLA-DRB1, -DQA1, and -DQB1 genotypes in patients with nasal polyposis. Laryngoscope 2000; 110(3 Pt 1): 422-425.
16. Kowalski ML, Grzegorczyk J, Pawliczak R, Kornatowski T, Wagrowska-Danilewicz M, Danilewicz M. Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivity. Allergy 2002; 57(6): 493-500.
17. Gosepath J, Brieger J, Mann WJ. New immunohistologic findings on the differential role of cyclooxygenase 1 and cyclooxygenase 2 in nasal polyposis. Am J Rhinol 2005; 19(2): 111-116.
18. Jantii-Alanco S, Holopainen E, Malmberg H. Recurrence of nasal polyps after surgical treatment. Rhinology 1989; 8: 59-64.
19. Milewski M, Mastalerz L, Nizankowska E. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1998; 101: 581-586.
20. Stevenson DD, Simon RA. Lack of cross reactivity between Rofecoxib and aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001; 108: 47-51.
21. Albu S, Tomescu E, Mexca Z, Nistor S, Necula S, Cozlean A. Recurrence rates in endonasal surgery for polyposis. Acta Otorhinolaryngol Belg 2004; 58(1): 79-86.
22. Zeiss CR, Lockey RF. Refractory period to aspirin in a patient with aspirin-induced asthma. J Allergy Clin Immunol 1976; 57(5): 440-448.
23. Schmitz-Schumann M, Schaub E, Virchow C. Inhalation provocation test with lysineacetylsalicylic acid in patients with analgetics-induced asthma. Prax Klin Pneumol 1982; 36(1): 17-21.
24. Patriarca G, Schiavino D, Nucera E, Papa G, Schinco G, Fais G. Prevention of relapse in nasal polyposis. Lancet 1991; 337(8755):1488.
25. Parikh AA, Scadding GK. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial. Laryngoscope 2005; 115(8): 1385-1390.
26. Stevenson DD, Simon RA, Mathison DA. Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 1980; 66: 82-88.
27. Stevenson DD, Pleskow WW, Simon RA, Mathieson DA, Lumry WR, Schatz M. Aspirinsensitive rhinosinusitis asthma: a double blind cross over study of treatment with aspirin. J Allergy Clin Immunol 1984; 73: 500-507.
28. Sweet J, Stevenson DD, Simon RA, Mathison DA. Long-term effects of aspirin desensitization - treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol 1990; 85: 59-65.
29. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996; 98(4): 751-758.
30. Berges-Gimeno P, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003; 111: 180-186.
31. Pfaar O, Spielhaupter M, Wrede H, et al. Aspirin desensitization on patients with aspirin intolerance and nasal polyps . a new therapeutic approach by the intravenous route. Allergologie 2006; 8: 322-331.
32. Schaefer D, Lindenthal U, Wagner M, Bolcskei PL, Baenkler HW. Effect of prostaglandin E2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa. Thorax 1996; 51 (9): 919-923.